Finasteride, a common hormone-blocking drug, reduces men’s risk of getting prostate cancer without increasing their risk of dying from the disease, according to long-term follow-up data.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
